Gordon W Duff

This inventor holds 23 USPTO granted patents and 6 published patent applications and 5 EPO patents, primarily in Cardiovascular Diagnostics. Top assignees: Interleukin Genetics, Inc., Cardioforecast Ltd., Sitokine Limited. Active years: 1997-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gordon W Duff. Retrieved from https://idiyas.com/inventor/gordon-w-duff

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 23 (Patent Applications = 6)

% Patents Active = 82.6

EPO Patents = 5 (Patent Applications = 3)

Average Co-Inventor Count = 3.0

ph-index = 9

Forward Citations = 288(Granted Patents)

Location History:

Sheffield, S10 3BZ, S Yorks, GB (1997)
Broomhill, Sheffield, GB (1997)
South Yorks, GB (2001)
South Yorkshire, GB (2004)
South York, GB (2004)
Sheffield, GB (2000 - 2021)
Newton, MA (US) (2022)

Company Filing History:

16 out of 20

Interleukin Genetics, Inc.

4. 3 out of 834,601

Other

patents

Years Active: 1997-2022

Loading Chart...

Areas of Expertise:

Cardiovascular Disease

Genetic Predisposition

Osteoporosis

Myocardial Infarction

Obstructive Airway Disease

Fetal Testing

Early-Onset Menopause

Sepsis Diagnosis

Restenosis

Inflammatory Disease

Diabetic Retinopathy

Asthma Susceptibility

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11486006 - Methods and kits for treating cardiovascular disease (2022-11-01),

2. 10894985 - Methods for predicting response to treatment (2021-01-19),

3. 10337070 - Methods and kits for treating cardiovascular disease (2019-07-02),

4. 10329620 - Methods and kits for treating cardiovascular disease (2019-06-25),

5. 7820383 - Method for diagnosing myocardial infarction (2010-10-26),

6. 7723028 - Diagnostics and therapeutics for osteoporosis (2010-05-25),

7. 6746839 - Diagnostics and therapeutics for an obstructive airway disease (2004-06-08),

8. 6733967 - Fetal testing for prediction of low birth weight (2004-05-11),

9. 6730476 - Methods of diagnosing early-onset menopause (2004-05-04),

10. 6720141 - Diagnostics and therapeutics for restenosis (2004-04-13),

11. 6713253 - Detecting genetic predisposition to sight-threatening diabetic retinopathy (2004-03-30),

12. 6706478 - Diagnostics and therapeutics for diseases associated with an IL-1 inflammatory haplotype (2004-03-16),

13. 6558905 - Diagnostics and therapeutics for osteoporosis (2003-05-06),

14. 6551785 - Diagnostics for bacterial meningitus (2003-04-22),

15. 6524795 - Diagnostics for cardiovascular disorders (2003-02-25),

Title: Innovator Spotlight: Gordon W Duff - Revolutionizing Cardiovascular Disease Treatment

Introduction: Meet Gordon W Duff, a prolific inventor based in Sheffield, GB, with an impressive total of 23 patents to his name. Duff is a visionary in the field of healthcare innovation, particularly known for his groundbreaking work in developing methods and kits for treating cardiovascular disease.

Latest Patents: Among his latest patents, Duff has introduced innovative methods and kits for treating cardiovascular disease. Additionally, his invention includes methods for predicting responses to treatment based on genotype-specific differential expression of IL-1, enabling personalized anti-inflammatory drug dosing to reduce toxicity and adverse events while ensuring optimal clinical benefits.

Career Highlights: Duff's remarkable career includes notable contributions at companies such as Interleukin Genetics, Inc., where he has played a pivotal role in driving advancements in personalized medicine and precision healthcare. His commitment to improving patient outcomes through innovative solutions has earned him recognition as a leader in the field of medical inventions.

Collaborations: Throughout his career, Duff has collaborated with esteemed professionals in the industry, including his coworkers Kenneth S Kornman and Francesco Saverio di Giovine. Together, they have leveraged their expertise to further enhance the effectiveness of treatments for cardiovascular disease and inflammation-related disorders.

Conclusion: Gordon W Duff's dedication to transforming the landscape of cardiovascular disease treatment through his innovative methods and kits underscores his position as a pioneering inventor in the healthcare sector. His relentless pursuit of excellence and commitment to personalized medicine continue to pave the way for improved patient care and outcomes in the field of cardiovascular health.

Profile summary based on public USPTO records.